Top Markets
#1 Black Phoenix Black Phoenix +736.72%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +18.03%
#3 Verus Coin Verus Coin +14.55%
#4 Gas Gas +9.22%
#5 MetaDAO MetaDAO +7.78%
#6 Ontology Ontology +5.23%
#7 wojak wojak +5.13%
#8 StonkBroker StonkBroker +4.52%
#9 Polymesh Polymesh +3.86%
#10 Wibx Wibx +3.79%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
GRAIL Inc. GRAIL Inc.

GRAIL Inc.

GRAL
Kedudukan dalam Saham #4687
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Harga Saham
$79.40
Modal Pasaran
$3.41B
Perubahan (1 hari)
-3.80%
Perubahan (1 tahun)
133.05%
Negara
US
Perdagangan GRAIL Inc. (GRAL)

Kategori

Healthcare
Pendapatan untuk GRAIL Inc. (GRAL)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini GRAIL Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi GRAIL Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH